LDC7559
LDC7559 is a gasdermin D (GSDMD) inhibitor via blocking neutrophil extracellular trap (NET) in the late stages [1].
Product Specifications
CAS Number
2407782-01-6
UNSPSC
12352005
Target
Pyroptosis
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/LDC7559.html
Concentration
10mM
Purity
99.51
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC1=C(C=CC=C1)C2=NN3C(COC(C=C(NC(C)=O)C=C4)=C4C3)=C2
Molecular Formula
C20H19N3O3
Molecular Weight
349.38
References & Citations
[1]Spel L, et al. Gasdermin D opens the way for NETs. Nat Rev Rheumatol. 2018 Dec;14 (12) :690-692.|[2]Sollberger G, et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci Immunol. 2018 Aug 24;3 (26) . pii: eaar6689.|[3]Ankit Pandeya, et al. Gasdermin D (GSDMD) as a New Target for the Treatment of Infection. Medchemcomm. 2019 Apr 4;10 (5) :660-667.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH032975-01 10 µg
Recombinant Human PTPN6/SH-PTP1 Protein (His Tag)
Sign In for Pricing
View Details PKSH032975-02 50 µg
Recombinant Human PTPN6/SH-PTP1 Protein (His Tag)
Sign In for Pricing
View Details 
TRC-B233645-50MG 50 mg
Benzyl (2S)-2-carbobenzyloxyamino-6-hydroxyhexanoate
Sign In for Pricing
View Details